[CDKN2A在患有扩散型大B细胞淋巴瘤的患者中删除副本数量的预后值]
Wei-Yuan Ma1, Le-Tian Shao2, Wen-Xin Tian3
1Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uygur Autonomous Region, China.
Zhongguo shi yan xue ye xue za zhi
|May 6, 2025
概括
CDKN2A拷贝数删除是扩散型大B细胞淋巴瘤 (DLBCL) 整体存活率的独立风险因素. 识别这种删除可以帮助预测DLBCL患者的预后.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
- 血液学 血液学 血液学
相关概念视频
Sensitivity, Specificity, and Predicted Value
134
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
134
Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291


